[
1. Marthe AJ. Becker, Jan H. Cornel, Peter M. van de Ven, Albert C. van Rossum, Cornelis P. Allaart, Tjeerd Germans. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2018 Sep;11(9):1274-1284. doi: 10.1016/j.jcmg.2018.03.006.10.1016/j.jcmg.2018.03.006
]Search in Google Scholar
[
2. Patel, AR Kramer CM. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Non-Ischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2017 October;10(10 Pt A):1180–1193. doi:10.1016/j.jcmg.2017.08.005.10.1016/j.jcmg.2017.08.005
]Search in Google Scholar
[
3. Bogaert J, Dymarkowski S, Taylor AM et al. Clinical Cardiac MRI. second edition. Leuven:Springer; 2012.10.1007/978-3-642-23035-6
]Search in Google Scholar
[
4. Myerson SG, Francis J, Neubauer S. Carrdiovascular Magnetic Resonance. Chapter 6. Ischaemic heart disease. Myocardial viability; 2010. p. 162-163.10.1093/med/9780199549573.003.06
]Search in Google Scholar
[
5. Pettersen SE, Khanji MY, Plein S, Lancelloti P, Bucciarelli-Duci C. European Association of Cardiovascular Imaging expedet consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. European Heart Journal – Cardiovascular Imaging. 2019 December; 20(12):1321-1331. https://doi.org/10.1093/ehjci/jez232.10.1093/ehjci/jez232
]Search in Google Scholar
[
6. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077-84.10.1056/NEJM200004133421502
]Search in Google Scholar
[
7. Disertori M, Quintarelli S, Mazzola S, Favalli V, Narula N, Arbustini E. The need to modify patient selection to improve the benefits of implantable cardioverterdefibrillator for primary prevention of sudden death in nonischaemic dilated cardiomyopathy. Europace. 2013;15:1693-701.10.1093/europace/eut228
]Search in Google Scholar
[
8. Nakahara S, Tung R, Ramirez RJ, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol. 2010;55:2355-65.10.1016/j.jacc.2010.01.041
]Search in Google Scholar
[
9. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108:704-10.10.1161/01.CIR.0000083725.72693.EA
]Search in Google Scholar
[
10. Gorgels AP, Gijsbers C, de Vreede- Swagemakers J, Lousberg A, Wellens HJ. Out-ofhospital cardiac arrest: the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J. 2003;24:1204-9.10.1016/S0195-668X(03)00191-X
]Search in Google Scholar
[
11. Stecker EC, Vickers C, Waltz J, et al. Populationbased analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-6.10.1016/j.jacc.2005.11.045
]Search in Google Scholar
[
12. Ponikowski P, Voors AA, Anker SD, et al. 2016ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force forthe diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200.10.1093/eurheartj/ehw128
]Search in Google Scholar
[
13. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:2793-867.10.1093/eurheartj/ehv316
]Search in Google Scholar
[
14. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.10.1056/NEJMoa013474
]Search in Google Scholar
[
15. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.10.1056/NEJMoa043399
]Search in Google Scholar
[
16. Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221-30.10.1056/NEJMoa1608029
]Search in Google Scholar
[
17. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol. 2008;52:181-9.10.1016/j.jacc.2008.04.006
]Search in Google Scholar
[
18. Nijveldt R, van der Vleuten PA, Hirsch A, et al. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. J Am Coll Cardiol Img. 2009;2:1187-94.10.1016/j.jcmg.2009.06.008
]Search in Google Scholar
[
19. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61:e6-75.10.1016/j.jacc.2012.11.007
]Search in Google Scholar
[
20. Ponikowski P, Voors AA, Anker SD, et al. 2016ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-200.10.1093/eurheartj/ehw128
]Search in Google Scholar
[
21. Leyva F, Taylor RJ, Foley PW, et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. Journal of the American College of Cardiology. 2012;60:1659-67. [PubMed: 23021326]10.1016/j.jacc.2012.05.054
]Search in Google Scholar
[
22. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson. 2012;14:27.10.1186/1532-429X-14-27
]Search in Google Scholar
[
23. Philip Haaf, Pankaj Garg, Daniel R. Messroghli, David A. Broadbent, John P. Greenwood, Sven Plein. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. Journal of Cardiovascular Magnetic Resonance. 2016;18:89 DOI 10.1186/s12968-016-0308-4.10.1186/s12968-016-0308-4
]Search in Google Scholar
[
24. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98:1436-41.10.1136/heartjnl-2012-302346
]Search in Google Scholar
[
25. aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210-6.10.1093/ehjci/jeu183
]Search in Google Scholar
[
26. h-Ici DO, Jeuthe S, Al-Wakeel N, Berger F, Kuehne T, Kozerke S, Messroghli DR. T1 mapping in ischaemic heart disease. Eur Heart J Cardiovasc Imag. 2014;15:597-602.10.1093/ehjci/jeu024
]Search in Google Scholar
[
27. Ferreira VM, Holloway CJ, Piechnik SK, Karamitsos TD, Neubauer S. Is it really fat? Ask a T1- map. Eur Heart J Cardiovasc Imaging. 2013;14:1060.10.1093/ehjci/jet095
]Search in Google Scholar
